FTLP8

Across TCGA pan-cancer cohorts, FTLP8 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated FTLP8 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher FTLP8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FTLP8 expression acts as an unfavorable survival marker, although some lineages such as THCA and LUSC show a favorable association.

BRCA, MESO, and BLCA are the cancer types where FTLP8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	II,III,IV	0.912	0.950	.003	57	view →
MESO	DFS	Tertile	All	0.153	0.506	.018	27	view →
BLCA	DFS	Tertile	IV	0.319	0.507	.005	24	view →
LIHC	OS	Quartile	All	0.679	0.827	.008	22	view →
STAD	OS	Quartile	II,III,IV	0.378	0.680	.017	13	view →
PAAD	OS	Tertile	All	0.275	0.506	.003	9	view →
COAD	DFS	Quartile	IV	0.320	0.548	.016	9	view →
LGG	DFS	Tertile	All	0.759	0.849	.008	9	view →
READ	OS	Tertile	IV	0.478	0.925	.003	9	view →
TGCT	DFS	Median	II,III,IV	0.750	0.996	.046	6	view →
THCA	OS	Tertile	All	1.000	0.923	.040	6	view →
SARC	DFS	Tertile	All	0.170	0.426	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

FTLP8–BRCA (DFS)

Open the BRCA breakdown →